2022 Volume 71 Issue 2 Pages 375-380
Blood glucose level control in pregnant women with diabetes mellitus is important to prevent maternal and infant complications. However, severe hypoglycemia is often a problem for pregnant women with type 1 diabetes. A sensor-augmented pump (SAP) is a device that combines CSII and CGM and can strictly manage blood glucose level. In this study, we experienced a case of blood glucose level management using SAP from before pregnancy. The patient was 30 years old and developed type 1 diabetes mellitus. Her HbA1c level was poorly controlled at around 9% on MDI. At the age of 34, she wanted to have a baby and SAP was introduced. Her HbA1c level at her first outpatient visit was 8.8%. The HbA1c level decreased after the introduction of SAP and was 6.3% at the time of pregnancy. At 37 weeks and 3 days, she delivered a 3,292 g baby with no maternal or infant complications. In this patient, SAP was used effectively, and strict control of blood glucose level was achieved. The use of SAP is expected to reduce the risk of maternal and infant complications, and it is important to use it under appropriate guidance.
